Pregnant people with SARS-CoV-2 infection have obstetric and medical complications during and after pregnancy.1 Receiving COVID-19 vaccine reduces these complications by 90%.2 However, vaccine uptake in pregnancy remains low. As of January 15, 2022, only 42.6% of pregnant people were fully vaccinated, with 24.4% receiving at least 1 vaccine dose during pregnancy.3 To address this public health challenge, we designed and validated a survey to identify strategies to address vaccine-hesitancy in pregnant people. The objective of this study was to investigate which maternal self-reported attitudes and beliefs are associated with COVID-19 vaccine uptake during pregnancy.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: February 25, 2022.
Published: April 14, 2022. doi:10.1001/jamanetworkopen.2022.7430
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Cui Y et al. JAMA Network Open.
Corresponding Author: Anna Palatnik, MD, Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI, 53226 (firstname.lastname@example.org).
Author Contributions: Dr Palatnik had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: All authors.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Cui, Palatnik.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Cui.
Administrative, technical, or material support: Binger, Palatnik.
Supervision: Cui, Palatnik.
Conflict of Interest Disclosures: Dr Palatnik reported grants from the American Heart Association and grants from Advancing Healthier Wisconsin/Medical College of Wisconsin Clinical and Translational Science Institute outside the submitted work. No other disclosures were reported.
Funding/Support: Dr Palatnik is supported by the American Heart Association Career Development Award 847482.
Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Meeting Presentation: This paper was presented, in part, at the 42nd Annual Pregnancy Meeting of the Society for Maternal-Fetal Medicine; January 31 to February 5, 2022; virtual.
Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:
It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.
You currently have no searches saved.
You currently have no courses saved.